Table of Contents
SAN FRANCISCO — McKesson Corp. has appointed Brian Tyler as executive vice president of corporate strategy and business development.
 |
Brian Tyler |
The pharmaceutical distributor said late Thursday that with the move, effective immediately, Tyler will report to chairman and chief executive officer John Hammergren and become a member of the executive committee.
Tyler succeeds Marc Owen, who joined McKesson Specialty Health as president earlier this year.
McKesson noted that the appointment fills a crucial role for the company. Tyler will guide strategy development with McKesson’s business unit leaders, help foster innovation and source acquisitions that add new growth opportunities for the company.
Plans call for Tyler to stay on as president of McKesson’s U.S. Pharmaceutical business as the company searches for a successor.
"With his deep understanding of the health care industry and relationships in the manufacturer, physician, hospital, and pharmacy markets, Brian Tyler is exceptionally qualified to lead our corporate strategy and business development team," Hammergren said in a statement. "His experience as president of McKesson’s U.S. Pharmaceutical, Medical-Surgical and Specialty businesses provides a unique perspective on the challenges and opportunities facing our customers as health care reform drives further convergence throughout the industry.”
A 15-year McKesson veteran, Tyler has served as senior vice president of strategy and business development for McKesson Distribution Solutions, overseeing strategic planning, joint ventures, alliances and other business development activities for McKesson’s pharmaceutical distribution, medical-surgical, health solutions and retail automation groups.
After his role in strategy and business development, Tyler ran McKesson’s Specialty Care Solutions and Medical-Surgical businesses until assuming his most recent position as president of U.S. Pharmaceutical.
